Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
PHASE3
This study \[contRAst 1 (201790: NCT03980483)\] is a phase 3, randomized, m...
A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate
PHASE2
This study will evaluate immune response following administration of zoster...
Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors
PHASE3
This study will test if CP-690,550 is safe and effective in rheumatoid arth...